CN Patent

CN113164382A — 伊潘立酮的贮库施用

Assigned to Vanda Pharmaceuticals Inc · Expires 2021-07-23 · 5y expired

What this patent protects

本文公开了制备和施用结晶伊潘立酮的可注射贮库制剂的方法。

USPTO Abstract

本文公开了制备和施用结晶伊潘立酮的可注射贮库制剂的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN113164382A
Jurisdiction
CN
Classification
—
Expires
2021-07-23
Drug substance claim
No
Drug product claim
No
Assignee
Vanda Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.